Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
3,089 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Phase 2a Randomized Placebo-Controlled Human Challenge Trial of the Respiratory Syncytial Virus L-Protein Inhibitor S-337395 for Respiratory Syncytial Virus Infection.
Byrne S, Baba T, Kawaguchi N, Yamamoto A, Nakano Y, Dorrepaal C, Londt B, Mann A, Veselinski N, Uehara T. · Clin Infect Dis · 2026 · cited 0 timesOpen accessclinical trial, phase ii, randomized controlled trial
- Cost-effectiveness of respiratory syncytial virus vaccines in post-marketing settings: a systematic review and meta-analysis.
Mu M, Deng Y, Du Z, Zhao Y. · Infect Dis Poverty · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus in Infants and Children: An Updated Systematic Review and Network Meta-analysis.
Xiong J, Bai C, Sun M, Estill J, An C, Ge L. · Drugs · 2026 · cited 0 timessystematic review
- Spatiotemporal analysis of influenza, pneumonia, and respiratory syncytial virus in association with environmental factors: A systematic review.
Islam MM, Noor FM, Singh V, Lam T, Hu W, Cortes-Ramirez J. · Public Health · 2026 · cited 0 timessystematic review
- Respiratory Syncytial Virus Transmission in Closed Community Settings That Include Children: A Systematic Review and Meta-Analysis.
Saravanos GL, Takashima M, El-Heneidy A, King C, Ross M, Williams A, Ware RS, Britton PN. · Influenza Other Respir Viruses · 2026 · cited 1 timesOpen accessmeta-analysis, systematic review
- Cardiac Complications of Infections Due to Respiratory Syncytial Virus and Human Metapneumovirus: A Systematic Review and Pooled Analysis of Clinical Features.
Riccò M, Pipitò L, Costantino C, Bottazzoli M, Manzoni P, Falcone M, Giuri PG, Cascio A. · Viruses · 2026 · cited 0 timesOpen accesssystematic review, review-article
- The epidemiology of respiratory syncytial virus (RSV) in hospitalized children in Europe before the widespread implementation of new RSV prophylactic strategies: A systematic review and meta-analysis.
Berikopoulou MM, Giavasoglou DK, Konstantopoulou A, Gountas I, Siahanidou T, Michos A. · J Clin Virol · 2026 · cited 0 timesmeta-analysis, systematic review
- Systematic review of the mutations in the active antigenic site Ø of the prefusion F protein of the Respiratory Syncytial Virus (RSV) following the implementation of monoclonal antibody prophylaxis.
Berikopoulou MM, Tatsi EB, Siahanidou T, Michos A. · Vaccine · 2026 · cited 0 timessystematic review
- Efficacy and safety of respiratory syncytial virus vaccines.
Saif-Ur-Rahman KM, King C, Whelan SO, Blair M, Donohue S, Madden C, Kothari K, Sommer I, Harder T, Dauby N, Moustsen-Helms IR, Ruta S, Frère J, Schönfeld V, Poukka E, Lutsar I, Olsson K, Melidou A, Adel Ali K, Dwan K, Devane D. · Cochrane Database Syst Rev · 2025 · cited 12 timesmeta-analysis, systematic review
- Burden and Characteristics of Respiratory Syncytial Virus-Associated Bronchiolitis in Hospitalized Infants in Italy: A Systematic Review.
Bechini A, Salvati C, Del Riccio M, Bonito B, Stancanelli E, Bruschi M, Ionita G, Iamarino J, Bentivegna D, Buscemi P, Ciardi G, Cosma C, Stacchini L, Bega M, Schirripa A, Bertizzolo L, Muzii B, Azzi MV, Parisi S, Trippi F, Bonanni P, Boccalini S. · Immun Inflamm Dis · 2026 · cited 0 timesOpen accesssystematic review, review-article
- The Burden of Respiratory Syncytial Virus in Children With Acute Otitis Media: A Systematic Review and Meta-Analysis.
Kenmoe S, Dozier M, Liang J, Jenkins R, Nair H. · Influenza Other Respir Viruses · 2026 · cited 2 timesOpen accessmeta-analysis, systematic review
- Burden of Respiratory Syncytial Virus Infection in Immunocompromised Adults: A Systematic Review of the Evidence From High-Income Countries.
Saeedi P, Curtis JR, Nissen M, Oluwayi K, Pirçon JY, Vatsa B, Hulstrøm V, Penders Y. · Infect Dis Ther · 2026 · cited 1 timesOpen accesssystematic review, review-article
- Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults ≥ 50 Years of Age.
Roussy JF, Dennis P, Gupta AK, Wallace G, Abitbol A, Aggarwal N, Surber JG, Lee T, Smith BA, Gérard C, Hailemariam HA, David MP, Jastorff AM, Van der Wielen M, RSV-020 Study Group. · Clin Infect Dis · 2026 · cited 4 timesOpen accessclinical trial, phase iii, randomized controlled trial
- Burden of infection and hospitalization from respiratory syncytial virus-associated acute lower respiratory tract infections in Chinese children: Modeling of national, regional, and provincial estimates.
Liu Z, Wang X, Hu Y, Duan X, Xu S, Ge Q, Zhu W, Zhao J, Yao Y, Wang W. · Vaccine · 2026 · cited 0 timesmeta-analysis, systematic review
- Efficacy and safety of monoclonal antibodies against respiratory syncytial virus disease in premature infants: a systematic review and network meta-analysis.
Liu S, Wang Y, Cao Y, Song H, Tian Z, Li X, Huang L. · Front Pediatr · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- The impact of maternal respiratory syncytial virus vaccination on infant and perinatal outcomes: a systematic review and meta-analysis of randomized controlled trials.
Lopes JR, Martins Esteves I, Dias SO, da Silva FMTDFG, da Silva GCDM, Libonati NB, Gasparetti RM, Nau AL. · J Perinatol · 2026 · cited 2 timesmeta-analysis, systematic review
- Immunogenicity and Safety of Co-administration of Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine With 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years: A Randomized, Non-inferiority Trial.
Leroux-Roels I, Lins M, Surowitz R, Pragalos A, Jua PKTG, Wauters D, Jayadev A, Akite JE, Jastorff AM, Cárdenas V, Van der Wielen M, RSV-019 study group . · Clin Infect Dis · 2026 · cited 3 timesOpen accessclinical trial, phase iii, equivalence trial
- Programmed cell death in human respiratory syncytial virus infection.
Yao P, Ma C, Liu C. · Front Cell Infect Microbiol · 2025 · cited 1 timesOpen accesssystematic review, review-article
- Immunogenicity and Safety of Coadministration of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine and a COVID-19 mRNA Vaccine in Adult s Aged ≥50 Years: A Phase 3, Randomized, Noninferiority Trial.
Bonten M, Essink B, Hanning N, Leroux-Roels I, Masuet-Aumatell C, Martinez SN, Hailemariam HA, Jandari G, Kwo Ton Ge Jua P, Servais C, Valenciano S, Jastorff AM, Cárdenas V, Van der Wielen M. · Clin Infect Dis · 2026 · cited 2 timesOpen accessclinical trial, phase iii, equivalence trial
- Efficacy, Immunogenicity, and Safety of an Investigational Maternal Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine.
Banooni P, Gonik B, Epalza C, Reyes O, Madhi SA, Gomez-Go GD, Zaman K, Llapur CJ, López-Medina E, Stanley T, Kantele A, Huang LM, Mussi-Pinhata MM, Dewulf J, Langley JM, Seidl C, Ota M, Kirabo M, Anspach B, Dieussaert I, Henry O, Kim JH, Picciolato M, investiGational RSV mAternal vacCinE (GRACE) Study Group. · Clin Infect Dis · 2026 · cited 13 timesclinical trial, phase iii, research support, non-u.s. gov't
- Point-of-Care Nucleic Acid Amplification Tests for Respiratory Syncytial Virus Detection in Children and Adults: A Systematic Literature Review.
Date K, Fowler K, Baniecki ML, Perez KK, Toussi SS, Thomas E, Schneider KT, Ruiz O, Seabroke S, Chatzikonstantinidou K, Sarabia LE, Gessner B, Begier E. · Infect Dis Ther · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Meta-analysis of the efficacy of palivizumab versus nirsevimab at preventing medically attended respiratory syncytial virus infections in non-hospitalized preterm infants.
Fullarton J, Paes B, Waghorne N, Keary I, Rodgers-Gray B, Carbonell-Estrany X. · Hum Vaccin Immunother · 2026 · cited 1 timesOpen accessmeta-analysis, brief-report
- The risk of cardiac disease events after respiratory syncytial virus disease: a systematic literature review and meta-analysis.
Montiel J, Williams E, Robles-Rodríguez WG, Chatzikonstantinidou K, Carrió E, Seabroke S, Hall-Murray C, Date K, Falsey AR, Walsh EE, Begier E, Gessner B. · Eur Respir Rev · 2026 · cited 7 timesOpen accessmeta-analysis, systematic review
- A randomised, double-blind, multicentre, placebo-controlled phase 3 efficacy, safety, and immunogenicity study of an Ad26.RSV.preF/RSV prefusion F-protein vaccine for the prevention of respiratory syncytial virus-mediated lower respiratory tract disease in adults aged 60 years and older.
Comeaux CA, Testa M, Gymnopoulou E, Bastian AR, Nogueira ML, Pan H, Zhu F, Fursenko V, Smith WB, Junquera P, Menten J, Loi M, Effiom EB, Jastorff AM, Weber K, Falsey AR, Callendret B, Heijnen E. · EBioMedicine · 2026 · cited 0 timesOpen accessclinical trial, phase iii, multicenter study
- Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345.
Mayer EF, Falsey AR, Wolfe CR, Herc E, Burns F, Kabbani D, Kumar D, Mannan A, She F, Lan L, McGrath S, Kapoor A, Priddy F. · Clin Infect Dis · 2026 · cited 3 timesOpen accessclinical trial, phase iii, research support, non-u.s. gov't
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.